Immunotech Laboratories, Inc. is a drug development company. The company is headquartered in Glendale, California and currently employs 4 full-time employees. The company went IPO on 2002-01-07. The firm is also focused on the commercialization of its proprietary proteins known as Irreversible Pepsin Fraction (IPF) ITV-1 for the treatment of debilitating infectious diseases, such as human immunodeficiency virus (HIV) and Hepatitis Type C.
Follow-Up Questions
What is the price performance of IMMB stock?
The current price of IMMB is $0.0001, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Immunotech Laboratories Inc?
Immunotech Laboratories Inc belongs to Biotechnology industry and the sector is Health Care
What is Immunotech Laboratories Inc market cap?
Immunotech Laboratories Inc's current market cap is $57.4K
